Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Endoskopie in Österreich (Stand 2010)
Kardiologie in Österreich (Stand 2006)
Osteologie in Österreich (Stand 2016)
Fachbücher
Patientenliteratur
Grunert S, Ebel D, Schlack W, Thämer V Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28 PDF Summary Overview
| ||||||||||||
Figure/Graphic 3: Magnesium - Linksventrikulärer Druck Left ventricular pressure (LVP) during intracoronary magnesium aspartate use (A-upper panel) and intravenous magnesium potassium aspartate use (B-lower panel). Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of left anterior descending artery reperfusion; Mg i.c. = time period when magnesium aspartate or vehicle was infused into the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD |
Figure/Graphic 3: Magnesium - Linksventrikulärer Druck
Left ventricular pressure (LVP) during intracoronary magnesium aspartate use (A-upper panel) and intravenous magnesium potassium aspartate use (B-lower panel). Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of left anterior descending artery reperfusion; Mg i.c. = time period when magnesium aspartate or vehicle was infused into the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or vehicle was infused intravenously; values are means +/- SD |